Skip to main content

Advertisement

How I Read Cancer Imaging Studies: The Master Class Series

Surprisingly, in contrast to the literature regarding the outcomes of imaging, the methods that underpin the generation of a report and how to communicate the findings cogently to referring clinicians remains something of a “black box”.

This series of articles appearing in Cancer Imaging details experts in various modalities detailing their approach to reporting scans in particular disease settings. I hope you will be excited to discover data traditionally locked into the brains of experts and only intermittently shared with their own direct trainees or alternatively, at often expensive masterclass presentations.

  1. Review

    How we read FCH-PET/CT for prostate cancer

    Over the last decade, 18F-fluorocholine positron emission tomography/computed tomography (FCH-PET/CT) has gained in popularity for the staging and restaging of patients with prostate cancer (PCa). However, despit...

    Jean-Mathieu Beauregard and Alexis Beaulieu

    Cancer Imaging 2016 16:41

    Published on: 6 December 2016

  2. Review

    How We Read Oncologic FDG PET/CT

    18F-fluorodeoxyglucose (FDG) PET/CT is a pivotal imaging modality for cancer imaging, assisting diagnosis, staging of patients with newly diagnosed malignancy, restaging following therapy...

    Michael S. Hofman and Rodney J. Hicks

    Cancer Imaging 2016 16:35

    Published on: 18 October 2016

  3. Review

    MRI of paediatric liver tumours: How we review and report

    Liver tumours are fortunately rare in children. Benign tumours such as haemangiomas and cystic mesenchymal hamartomas are typically seen in infancy, often before 6 months of age. After that age, malignant hepa...

    Susan C. Shelmerdine, Derek J. Roebuck, Alexander J. Towbin and Kieran McHugh

    Cancer Imaging 2016 16:21

    Published on: 15 August 2016

  4. Review

    68Ga-PSMA ligand PET/CT in patients with prostate cancer: How we review and report

    Recently, positron emission tomography (PET) imaging using PSMA-ligands has gained high attention as a promising new radiotracer in patients with prostate cancer (PC). Several studies promise accurate staging ...

    Isabel Rauscher, Tobias Maurer, Wolfgang P. Fendler, Wieland H. Sommer, Markus Schwaiger and Matthias Eiber

    Cancer Imaging 2016 16:14

    Published on: 8 June 2016

  5. Review

    MRI of endometrium cancer – how we do it

    Endometrial cancer is the most common malignancy of the female pelvis. New concepts in endometrial cancer treatment emphasize the value of MRI as a major predictor of lymph node metastasis and tumour recurrenc...

    Matthias Meissnitzer and Rosemarie Forstner

    Cancer Imaging 2016 16:11

    Published on: 9 May 2016

  6. Editorial

    How I read cancer imaging studies: the master class series

    The generation of a report of findings and a conclusion for an imaging study is a fundamental process in the diagnostic work-up of cancer patients and plays a critical role in treatment decisions. It is theref...

    Rodney J. Hicks

    Cancer Imaging 2016 16:8

    Published on: 11 April 2016

  7. Review

    Prostate MRI based on PI-RADS version 2: how we review and report

    Prostate imaging and interpretation is based on prostate imaging reporting and data system version 2 (PI-RADS™ v2) providing clinical guidelines for multiparametric magnetic resonance imaging (mpMRI) of the pr...

    Philipp Steiger and Harriet C. Thoeny

    Cancer Imaging 2016 16:9

    Published on: 11 April 2016

Advertisement